ProSure® References
  1. Guarcello M, Riso S, D’Andrea F. EPA-enriched oral nutritional support in patients with lung cancer: Effects on nutritional status and quality of life. Nutr Ther & Metab. 2006;24:168-175.
  2. Bayram I, Erbey F, Celik N, et al. The use of a protein and energy dense eicosapentaenoic acid containing supplement for malignancy-related weight loss in children. Pediatr Blood Cancer. In press 2009.
  3. Ryan A, Reynolds JV, Healy L, et al. Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg. 2009;249:355-363
  4. van der Meij B, Languis J, van Adrichem V, et al. A double blind randomized controlled trial on oral nutrition supplementation of omega-3 fatty acids in non-small cell lung carcinoma. Clin Nutr. 2008;3:111 (P193b).
  5. Fearon K, von Meyenfeldt M, Moses K, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomized double-blind trial. Gut. 2003;52:1479-1486.
  6. von Meyenfeldt M, Fearon K, Moses A, et al.  Weight is associated with improved quality of life in patients with cancer cachexia consuming an energy and protein dense, high n-3 fatty acid oral supplement. Proc Am Soc Clin Oncol. 2002;21:385A.
  7. Moses A, Slater C, Preston T, et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004;90:996-1002.
  8. Bauer JD, Capra S. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy—a pilot study. Support Care Cancer. 2005;13:270-274.
  9. Barber M, Ross J, Voss L, et al. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Can. 1999;81:80-86.
  10. Blanco F, et al. Benefit of a therapeutic nutritional product on HIV+ patients. ESPEN. 2006.
  11. Read HG, Beale P, Volker D, Smith N, Childs A, Clark S. Nutrition intervention using an eicosapentaenoic acid-containing supplement in patients with advanced colorectal cancer. Support Care Cancer. 2007;15:301-307.
  12. Capuano G, et al. Critical considerations on the use of a protein and energy dense omega-3 enriched sip feed in cancer patients. Rivista Italiana di Nutri Parent e Enterale. 2005;23:43-46.
  13. Weed HG, et al. Impact of a protein and energy dense nutritional supplement containing eicosapentaenoic acid on weight-losing patients with head and neck cancer. Proc Am Soc Clin Oncol 2005;8112A.
  14. Jatoi A, Rowland K, Loprinzi CL, et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15;22(12):2469-2476.